Taimei Technology
Taimei Technology is a Chinese clinical research technology company providing the TrialOS digital collaboration platform and a suite of 40+ software products — including EDC, CTMS, eTMF, pharmacovigilance, and AI agents — serving 1,600+ pharmaceutical companies, CROs, and clinical trial institutions.
- Company typePublic
- Founded2013
- HeadquartersJiaxing, China
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Taimei Technology does
Taimei Technology (浙江太美医疗科技股份有限公司) is a Chinese clinical research technology company founded in 2013 and listed on the Hong Kong Stock Exchange (02576.HK) since October 8, 2024. Headquartered in Jiaxing with an administrative office in Shanghai, the company operates an integrated digital platform — anchored by TrialOS — that connects pharmaceutical sponsors, CROs, clinical trial sites, SMOs, patients, and regulators on a unified collaboration infrastructure. The company reports ~60% market share in innovative drug clinical development in China and serves 1,600+ pharmaceutical companies and CROs, ~700 clinical trial institutions, and 370+ SMOs.
The platform spans the full clinical development lifecycle through 40+ software modules, including eCollect (EDC), eBalance (IWRS/RTSM), eCooperate (CTMS), eArchives (eTMF), eImage (medical imaging evaluation), eSafety (pharmacovigilance), eMonitoring/iRMS (remote monitoring), and site-facing tools such as GCP-X and IIT-EDC with deep integrations to hospital HIS, LIS, EMR, and PACS systems. In 2024-2025, the company layered an AI-native offering on top of this base: the Wiz.AI platform powered by a proprietary DLA (Data Lifecycle Automation) framework, plus modular AI Agents including iDM (data management), iCTA (document management), and iPV (pharmacovigilance). Adjacent product lines include the PharmaOS digital marketing suite (ONECEM, ONEInsight, Boundless 无界), TrialPartner (digital SMO services), and Boundless AI Training (无界AI陪练) for pharmaceutical sales representatives.
Revenue is generated primarily through SaaS platform subscriptions (annual or multi-year contracts) supplemented by professional services for implementation, training, and consulting. Pricing is not publicly disclosed and is quote-based, tailored to customer size, scope, and number of users. Go-to-market is enterprise field sales targeting large pharmaceutical companies, biotech firms, and CROs, supplemented by channel partnerships with regional CROs across Asia Pacific and industry event participation. The company has expanded internationally with offices in the US (Boston and Pleasanton, CA), Singapore (APAC regional HQ since February 2023), and Seoul, alongside partnerships extending into Malaysia, South Korea, and Australia. Founded by Chairman and CEO Zhao Lu, Taimei employs approximately 800 cross-disciplinary experts spanning pharmaceutical and IT domains.
Taimei Technology firmographics
Firmographics- Name
- Taimei Technology
- Legal name
- 浙江太美医疗科技股份有限公司 (Zhejiang Taimei Medical Technology Co., Ltd.)
- Website
- https://taimei.com
- Company type
- Public
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Taimei Technology is a Chinese clinical research technology company providing the TrialOS digital collaboration platform and a suite of 40+ software products — including EDC, CTMS, eTMF, pharmacovigilance, and AI agents — serving 1,600+ pharmaceutical companies, CROs, and clinical trial institutions.
- Ownership category
- akta.pro rank
Taimei Technology industry classification
Industry- Product category
- Clinical Trial Management & Life Sciences SaaS
- NAICS
- Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS) (HLACAOAC), eTMF & Trial Document Management (HLACAOAF), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
Keywords
Where Taimei Technology is headquartered
LocationHeadquarters
- HQ city
- Jiaxing
- HQ country
- China
- HQ region
- Asia
Offices9 records
Markets served
Taimei Technology business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscription: Subscription-based recurring revenue model providing access to the AI-powered clinical trial platform, including software modules, updates, and cloud infrastructure. Revenue is generated through annual or multi-year contracts with pharmaceutical companies and CROs.
- Professional Services: Implementation, training, and consulting services to support platform deployment and optimization for enterprise clients. Typically bundled with platform subscriptions.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Taimei Technology product offering
Product offeringCore offering
Taimei Technology provides a cloud-based Digital Intelligence Platform for Life Sciences, anchored by the TrialOS R&D Collaboration Platform that connects pharmaceutical sponsors, CROs, SMOs, hospitals, investigators and patients on a unified login portal. On top of this collaboration layer it sells 40+ SaaS modules covering electronic data capture (eCollect EDC), randomization and trial supply (eBalance IWRS), CTMS (eCooperate), eTMF (eArchives), eCOA, pharmacovigilance (eSafety, eSAE), medical imaging (eImage), site management (eSMS, GCP-X, eMonitoring iRMS), decentralized trials (iDCT), and the newer AI agent products (iDM, iCTA, iPV) plus Wiz.AI, alongside the PharmaOS digital marketing suite (ONECEM, ONEInsight, Boundless).
Differentiator
Problem solved
Functional benefit
Brands
- TrialOS: Pharmaceutical R&D Collaboration Platform - a unified digital platform connecting pharmaceutical companies, hospitals, third-party providers, patients, and regulatory agencies.
- Wiz.AI
- PharmaOS
- 无界 (Boundless)
- ONECEM
- ONEInsight
Products and services
- TrialOS R&D Collaboration Platform Unified digital collaboration platform connecting pharmaceutical sponsors, hospitals, third-party providers, patients, and regulatory agencies to standardize processes, enable data flow, break data silos and boost efficiency in clinical research.
- eCollect (EDC) Electronic Data Capture system for clinical trials, enabling structured case report form entry, validation, and integration with downstream analytics.
- eBalance (RTSM / IWRS) Randomization and Trial Supply Management system with dynamic minimization and stratified randomization, multi-cohort support and automated supply chain optimization with dynamic resupply.
- eCOA Electronic Clinical Outcome Assessment solution for capturing patient-reported outcomes and clinical endpoints in clinical trials.
- eCooperate (CTMS) Clinical Trial Management System covering planning, monitoring, site management and progress tracking across multi-site studies.
- eArchives (eTMF) Electronic Trial Master File management system for organizing and maintaining regulatory-compliant trial documentation.
- eSafety Pharmacovigilance Compliance Management System Pharmacovigilance compliance system providing AE data collection, signal detection with intelligent alerts, automated ingestion of FDA/WHO/EMA safety data and compliance risk visualization.
- eSAE Clinical Trial Safety Information Management System Safety information management system for clinical trials, supporting serious adverse event (SAE) capture and reporting workflows.
- eImage Medical Imaging Evaluation System AI-powered medical imaging endpoint evaluation system for clinical trials, supporting remote image review and full-process online management with blinded independent reviews.
- TrialPartner Digital SMO Services Digital Site Management Organization services platform providing nationwide CRC matching and digital project management to connect sponsors with site management partners.
- eSitePro Clinical Trial Management Platform Clinical trial management platform for sites, supporting institutional trial workflows and oversight.
- eTrialPro Research Ward Management System Research ward management system for hospitals running investigator-initiated and sponsor-led trials, integrating with hospital information systems.
- GCP-X Intelligent Clinical Trial Platform Intelligent clinical trial platform for hospitals that integrates with EMR and PACS, consolidating medication logs, nursing records, pathology reports and genetic tests, with NLP processing of unstructured EMR data.
- IIT-EDC Research Data Collection System Research data collection system for investigator-initiated trials that synchronizes with HIS and LIS, supports CDISC ODM export and applies NLP structuring to EMR text.
- eScreening Subject Information Management System Subject information management system for screening, enrolling and tracking clinical trial participants.
- eMonitoring (iRMS) Intelligent Remote Monitoring System Intelligent Remote Monitoring System integrating data from HIS, LIS, EMR, PACS, prescriptions and pathology reports to provide a panoramic view of trial participants with facial recognition for identity verification.
- IDS Investigational Drug Services Investigational Drug Services module for managing investigational product dispensing, accountability and chain-of-custody at trial sites.
- iDCT Intelligent Decentralized Clinical Trial Intelligent Decentralized Clinical Trial solution enabling remote participation, telemedicine, eCOA and home-based trial activities.
- Paylite Financial Management System Financial management system for clinical trials, handling payments, budgeting and site financial tracking.
- eCollege Training Management System Training management system for clinical research personnel, supporting GCP training, certification tracking and continuing education.
- PharmaOS Digital Marketing Platform for Pharmaceuticals Integrated omni-channel marketing system and marketing data middle platform for pharmaceutical companies, breaking data silos to deliver end-to-end digital marketing solutions, refined sales management and decision support.
- ONECEM Omni-Channel Marketing Platform Omni-channel pharmaceutical marketing platform encompassing SFE (Sales Force Effectiveness), SCRM and Event+Engagement systems for pharmaceutical commercial teams.
- ONEInsight Marketing Data Platform AI-driven marketing data management platform with standard APIs, integrating CNKI, Wanfang, Hao Daifu, Baidu and Wikipedia data sources to deliver customer-centric insights and smart recommendations.
- Boundless Corporate Medical Interaction Platform Omnichannel digital marketing platform for corporate medical interactions, including the Boundless AI Training (无界AI陪练) module that uses LLM, RAG and high-fidelity TTS for medical sales representative role-play training.
- Wiz.AI Clinical Trial AI Platform AI platform for clinical trials with modular AI agents such as Wiz ProtocolCraft and Wiz DocuSync, integrating TrialOS SaaS with autonomous decision engines powered by the proprietary DLA framework.
- iDM Intelligent Data Management Agent AI-driven data management agent that parses protocols, automates CRF generation, builds data validation plans, performs intelligent real-time data review and integrates seamlessly with EDC.
- iCTA Intelligent Document Management Agent Intelligent document management agent that automates trial document classification, metadata extraction, quality control and completeness tracking to reduce compliance risk and inspection burden.
- iPV Intelligent Pharmacovigilance Agent AI-native pharmacovigilance agent with an iPV-intake module that automates SAE report entry, narrative reconstruction, conflict verification, query organization and translation quality control.
- Boundless AI Training (无界AI陪练) AI-powered sales representative training product using LLM, RAG and high-fidelity TTS to simulate virtual doctors with personality characteristics, enabling role-play training scenarios for pharmaceutical medical sales teams.
Companies that use Taimei Technology
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Taimei Technology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration12 records
AI capability16 records
Feature3 records
Taimei Technology partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- C&R ResearchcoreStrategic partnership for AI-powered clinical trial operations. C&R Research, a Korean CRO, collaborates with Taimei to integrate AI capabilities into clinical trial workflows, enhancing operational efficiency and data quality for trials conducted in South Korea and beyond.
- Shanghai United Imaging Healthcare Advanced Technology Research Institute (联影医疗高新技术研究院)coreStrategic cooperation for AI-driven imaging endpoint evaluation services. The partnership enables integration of United Imaging's medical imaging technology with Taimei's clinical trial platform, providing automated and standardized AI-powered assessment of imaging endpoints in clinical trials.
- Top Multinational Pharmaceutical Company (unnamed)coreStrategic cooperation on digital clinical development end-to-end solutions. The partnership focuses on providing comprehensive digital clinical trial solutions to accelerate drug development timelines and improve data quality across the client's global trial portfolio.
- Accenture ChinaminorStrategic cooperation memorandum signed with Accenture China for consulting and implementation services to support enterprise clients in deploying Taimei's digital clinical trial platform.
- CSI Medical ResearchcorePartnership with Singapore-based CRO CSI Medical Research for the clinical trial platform. CSI Medical Research distributes and implements Taimei's platform solutions across its customer base in Singapore and the Asia Pacific region.
- GreenLight ClinicalcorePartnership to accelerate clinical research through digital platform adoption. GreenLight Clinical leverages Taimei's platform to enhance its clinical trial service offerings to pharmaceutical sponsors.
- IHiS (now Synapxe)coreTender award for Ethics and Compliance Online System (ECOS). Taimei was awarded the tender by IHiS (now Synapxe), Singapore's national health technology agency, to provide an ethics and compliance management system for clinical trials in Singapore.
- Clinical Research MalaysiacoreCollaboration with Clinical Research Malaysia to support digital clinical trial operations in Malaysia. The partnership aims to enhance clinical research capabilities and efficiency across Malaysia's clinical trial ecosystem.
Scale indicators4 records
Recent moves9 records
Expansion highlights5 records
Taimei Technology competitors and assessment
Company assessmentEmerging players
- Castor: Castor provides a cloud-based EDC platform with decentralized trial capabilities — an emerging player focused on a portion of Taimei's broader clinical trial product portfolio.
- Y-Prime: Y-Prime specializes in IRT/RTSM and eCOA solutions for clinical trials — an emerging player with overlapping but narrower scope than Taimei's full clinical platform.
- RealTime Software Solutions: RealTime provides CTMS, eTMF, and site-focused clinical trial solutions — comparable to several modules in Taimei's portfolio, particularly eSitePro and CTMS offerings.
Broad incumbents
- IQVIA: IQVIA offers the E360 platform and other clinical technology solutions as part of its broader CRO and commercial services portfolio — a large established incumbent with overlapping but much broader offerings than Taimei's focused clinical trial suite.
Direct peers
- Veeva Systems: Veeva provides Vault CTMS, Vault EDC, eTMF, RTSM, and pharmacovigilance solutions on a unified cloud platform serving global pharma and CROs — the closest direct competitor to Taimei's TrialOS suite in clinical trial informatics.
- Medidata (Dassault Systèmes): Medidata's Rave platform provides EDC, CTMS, RTSM (Balance), eCOA, and imaging solutions for clinical trials — directly competing with Taimei's eCollect, eBalance, eCOA, and eImage products across global pharma.
- ArisGlobal: ArisGlobal provides LifeSphere Safety, Regulatory, and Clinical platforms with a strong focus on AI-native pharmacovigilance — directly comparable to Taimei's eSafety and iPV pharmacovigilance agent products.
- Clario: Clario specializes in eCOA, medical imaging, and respiratory solutions for clinical trials — directly comparable to Taimei's eCOA and eImage imaging endpoint evaluation capabilities.
- Signant Health: Signant provides eCOA, eConsent, RTSM, and imaging endpoint solutions for clinical trials — comparable to several modules in Taimei's product portfolio including eCOA, eBalance, and eImage.
- Oracle Health Sciences Clinical One: Oracle Clinical One unifies EDC, RTSM, supplies, CTMS, and eTMF on a single platform — a direct head-to-head competitor to Taimei's integrated clinical trial product suite, particularly for large enterprise pharma.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Taimei Technology social profiles
Digital presenceTaimei Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Taimei Technology leadership team
Management profileNumber of profiles
Profiles1 record
Taimei Technology subsidiaries and ownership
Company hierarchySubsidiaries3 records
Taimei Technology funding detail
Funding detailFunding overview
Funding rounds8 records
Investors17 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Taimei Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Taimei Technology
What does Taimei Technology do?
Taimei Technology provides a cloud-based Digital Intelligence Platform for Life Sciences, anchored by the TrialOS R&D Collaboration Platform that connects pharmaceutical sponsors, CROs, SMOs, hospitals, investigators and patients on a unified login portal. On top of this collaboration layer it sells 40+ SaaS modules covering electronic data capture (eCollect EDC), randomization and trial supply (eBalance IWRS), CTMS (eCooperate), eTMF (eArchives), eCOA, pharmacovigilance (eSafety, eSAE), medical imaging (eImage), site management (eSMS, GCP-X, eMonitoring iRMS), decentralized trials (iDCT), and the newer AI agent products (iDM, iCTA, iPV) plus Wiz.AI, alongside the PharmaOS digital marketing suite (ONECEM, ONEInsight, Boundless).
Is Taimei Technology a public or private company?
Taimei Technology is a public company. It is classified as public and is currently operating.
When was Taimei Technology founded?
Taimei Technology was founded in 2013. It employs 101 to 250 people.
Where is Taimei Technology based?
Taimei Technology is headquartered in Jiaxing, China, in the Asia region.
How does Taimei Technology make money?
Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are professional Services.
Who are Taimei Technology's main competitors?
Emerging players on record are Castor, Y-Prime and RealTime Software Solutions. IQVIA is listed as a broad incumbent. Direct peers are Veeva Systems, Medidata (Dassault Systèmes), ArisGlobal, Clario, Signant Health and Oracle Health Sciences Clinical One.
Does Taimei Technology have an API?
No public API is recorded for Taimei Technology.
What industry is Taimei Technology in?
Taimei Technology's product category is Clinical Trial Management & Life Sciences SaaS. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAC, Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS). Its NAICS code is 541511 and its SIC code is 8090.